| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Alexandria New Medical Center Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م6.97 |
| 52 Week High | ج.م9.25 |
| 52 Week Low | ج.م6.38 |
| Beta | -0.34 |
| 11 Month Change | -17.61% |
| 3 Month Change | -13.58% |
| 1 Year Change | -24.14% |
| 33 Year Change | 2.23% |
| 5 Year Change | 214.10% |
| Change since IPO | 1,703.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMES | EG Healthcare | EG Market | |
|---|---|---|---|
| 7D | -17.6% | -2.4% | 1.4% |
| 1Y | -24.1% | 43.3% | 62.5% |
Return vs Industry: AMES underperformed the EG Healthcare industry which returned 43.3% over the past year.
Return vs Market: AMES underperformed the EG Market which returned 62.5% over the past year.
Price Volatility
| AMES volatility | |
|---|---|
| AMES Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in EG Market | 9.0% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: AMES has not had significant price volatility in the past 3 months.
Volatility Over Time: AMES's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Bavaguthu Shetty | www.anmchosp.com |
Alexandria New Medical Center engages in the operation of a hospital in Egypt. The company’s hospital provides range of medical specialization services, including gynecology, general surgery, pediatrics, and other, as well as medical diagnostic and treatment services in various medical fields. It also operates children’s, neurology, sugar, liver, chest, cardiology, internal, oncology, dental, nose and ear, women’s, ophthalmology, nutrition, dermatology, blood disease, and rheumatology clinics; specialized units and centers; and dormitories.
Alexandria New Medical Center Fundamentals Summary
| AMES fundamental statistics | |
|---|---|
| Market cap | ج.م868.33m |
| Earnings (TTM) | ج.م3.05m |
| Revenue (TTM) | ج.م279.06m |
284.6x
P/E Ratio3.1x
P/S RatioIs AMES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMES income statement (TTM) | |
|---|---|
| Revenue | ج.م279.06m |
| Cost of Revenue | ج.م222.46m |
| Gross Profit | ج.م56.60m |
| Other Expenses | ج.م53.55m |
| Earnings | ج.م3.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 20.28% |
| Net Profit Margin | 1.09% |
| Debt/Equity Ratio | 3.7% |
How did AMES perform over the long term?
See historical performance and comparison